chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse referring to a patient of unknown age and gender. On 27-MAY-2015 the patient was vaccinated with a dose of improperly stored VAQTA (strength, lot#, dosage, frequency and route unspecified). The temperature excursion for VAQTA was unsupported with in-house stability data and the initial temperature excursion was on 15-OCT-2014. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
I have had swollen lymph node in the back of my throat, upper right side- it?s swollen to 10 x normal size- a large bulbous , red swollen area to the left of my uvula.
Pt stated dizzy, lightheaded, flushed, clammy after receiving 2nd dose of Pfizer (EW0191).
Fever and cold symptoms that were transient and resolved quickly- note that I do not know the time his illness started on 9/18- no box for "unknown".
she tested positive for COVID even after getting the Pfizer vaccine; she tested positive for COVID even after getting the Pfizer vaccine; lost sense of smell and taste; lost sense of smell and taste; cough; sniffles; body aches; This is a spontaneous report from a contactable consumer (Pfizer colleague) reported for a female patient.  An adult non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was not known if the patient had received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Reporter's friend told her that on an unspecified date, she was tested positive for COVID even after getting the Pfizer vaccine. She lost sense of smell and taste, cough, sniffles, body aches. Patient visited doctor or other healthcare professional office/clinic. It was unknown whether the patient received treatment for the events or not. The outcome of events were not recovered.  Information about lot/batch number has been requested.
Patient described having trouble breathing .  She said it felt as bad as collapsed lung she had in the past.
Narrative: 62 year old male patient with past medical history of mixed restrictive/obstructive lung disease, PE (on Eliquis), tobacco use disorder, alcohol use disorder, obesity, osteoarthritis, T2DM, BPH, and poor health literacy and poor medication compliance presenting with COVID pneumonia. He denies fever, chills, shortness of breath, chest pain, n/v/c/d. When asked why he came to the hospital before he knew he had COVID, he states that he was drinking like he usually does, and EMS found him and brought him here. He also states that his last drink was yesterday, and he states that he drinks hard liquor. Denies drug use. He states that he smokes too much but cannot further quantify. Per ED documentation, he presented to ED 6/7/2021 with dyspnea. Temp 100.4, HDS, SpO2 mid 90s on ROOM AIR. WBC 5K, Hb 13.7, Plt 142, Cr 1.1, BNP <100, cardiac markers negative. Blood cx drawn. CXR consistent with multifocal pneumonia. He was given albuterol nebulizer, azithromycin and ceftriaxone x1. Found to be COVID positive admitted. Admitted to floor 6/8, transferred to MICU 6/9 and intubated for increased oxygen requirements, extubated 6/16. Received tocilizumab 6/9, Dexamethasone (6/9 - 6/18), Remdesivir (6/8 - 6/18). Transferred to the floor 6/21 on 2L NC and weaned to room air on 6/23. Remained stable on room air for remainder of hospital course. Continued incentive spirometry. COVID IgG positive 6/19. Patient was discharged 6/25/2021 to Rehab facility but has had ongoing SOB ever since.
VACCINE TASTE (STRONG BITTER ODOR); INJECTION SITE REACTION; This spontaneous report received from a patient concerned a 73 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no past medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 08-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-MAY-2021, the subject experienced vaccine taste (strong bitter odor). On 08-MAY-2021, the subject experienced injection site reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vaccine taste (strong bitter odor) on 12-MAY-2021, and injection site reaction. This report was non-serious.
received expired dose as second booster; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired dose as second booster) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A, 939909, 028L20A and 039K20-2A) for COVID-19 prophylaxis.     The patient had no allergies.  Concurrent medical conditions included Blood pressure high. Concomitant products included METOPROLOL for Blood pressure high.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired dose as second booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received expired dose as second booster) outcome was unknown.            The patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine. He received the second booster dose of the Moderna COVID-19 vaccine on 02-Jun-2022 from an expired lot per the online lot lookup tool. The lot number per his vaccination card was 038A21A, which expired on 02-Sep-2021. He had no reaction to it. He did not seek medical care and had no similar event in the past. He did not had COVID positive test or diagnosis. No treatment information was provided.   This case was linked to MOD-2022-593404 (Patient Link).
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment medication were provided.    This case was linked to MOD-2021-392458 (Patient Link).
ACHES; BEING TOO HOT; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced aches, being too hot, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, aches and being too hot was not reported. This report was non-serious.
Reporting an incident of mixed doses of COVID-19 vaccine. Patient went to a different site for her second vaccine and was inadvertently given the one product instead of the other product. The vaccines were spaced by 28 days, and guidance was given not to repeat any doses. Patient did not have any immediate adverse reactions.
After the patient received the 2nd dose of Shingrix we came out of the immunization room.  The patient felt faint.  I had her sit down and place her head between her legs and I got her some water.  She sat there for a few minutes and felt better.  She then walked around the store for a little bit and stated that she felt fine and could go home.
One patient received a dose from one of the vials which were incorrectly stored; Upon receiving the vials in the frozen state, and were directly stored in the refrigerator.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One patient received a dose from one of the vials which were incorrectly stored) and PRODUCT STORAGE ERROR (Upon receiving the vials in the frozen state, and were directly stored in the refrigerator.) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One patient received a dose from one of the vials which were incorrectly stored) and PRODUCT STORAGE ERROR (Upon receiving the vials in the frozen state, and were directly stored in the refrigerator.). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One patient received a dose from one of the vials which were incorrectly stored) and PRODUCT STORAGE ERROR (Upon receiving the vials in the frozen state, and were directly stored in the refrigerator.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment details were provided.
Hospitalization with acute respiratory failure, hyponatremia and thrombocytopenia. Remdesivir and dexamthasone used
C/O muscle pain in right arm that bothers her mainly at rest. Pt is dental hygienist and pain does not bother her while working. Decribes pain as severe at times even waking her from sleep.
Information has been received from a physician concerning a 26 year old female who on approximately 25-JUN-2008 was vaccinated with a dose of GARDASIL vaccine (yeast). After receiving GARDASIL vaccine (yeast), the patient left the office and went to work. It was reported that on approximately 25-JUN-2008 the patient was on her feet all night at work, had an alcoholic beverage after work and when she was going home that night she had felt dizzy. The dizziness had lasted until the morning and got better on her own. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
I was 24 weeks pregnant via IVF with no  complications at the time of the COVID vaccine,  my daughter was born 8lbs 7oz  at 41 weeks gestation. After an uneventful induction by my OBGYN baby started having seizures 4 hours after birth. She was take to the ICU where they found Via MRI she had a Infarct of the right MCA with hemorrhage. Baby spent 2 weeks in the ICU and at this time is still on medication to control seizures and revived physical therapy for possible left sided deficits.
Called MD large localized reaction the size of parents hand.  Treatment Benadryl, ice, follow up with doctor.
Initial report received from a healthcare professional on 17 September 2014. This case is a part of cluster of 12 cases (same reporter, vaccine and vaccine lot number) and is linked to case numbers 2014SA129888, 2014SA129904, 2014SA129919, 2014SA129922, 2014SA129926, 2014SA129934, 2014SA129941, 2014SA129951, 2014SA129956, 2014SA129960 and 2014SA129963. A female patient, whose age was not reported, had received an intramuscular dose of FLUZONE QIV, (batch number UI158AA, dose, dose in series and site of vaccination was not reported) on 15 September 2014. The patient's illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects and medical conditions were unknown. The patient's concomitant medications were not reported. Any other vaccination within 4 week of vaccination was unknown. On 16 September 2014, one day after vaccination, the patient experienced chills, nausea, and body aches. Laboratory investigations and corrective treatment was not reported. At the time of this report the outcome of event was unknown. Documents held by sender: none.
Pfizer 4/7/21 and 4/28/21. Positive on 1/18/22
Vaccine administered on 11/12/13 on 11/14/13 my arm began to ache, the site swelled to the size of a lemon and itches a lot. If it gets bumped, it causes pain for a few minutes. It's also very red. It did not cause my breathing to be affected.
Patient arm swelled up where shot administered IM. Told her to keep an eye on it. Looks like it might bruised. Told her to call MD and watch for worsening. Compress and BENADRYL if needed.
Her left arm started hurting at injection site on same day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Her left arm started hurting at injection site on same day) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (Her left arm started hurting at injection site on same day). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (Her left arm started hurting at injection site on same day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also  include  Vitamins.
Pressure and slight numbness down arm. Pm 09/03/15, 1/2 a day. Pain in knees just from getting from sitting position, pm 09/03/15. Ongoing, only slight pm 09/07/15. Hip pain radiating from knees. Hives/rash 09/04/15 unknown. First left arm where injection administered, then right forearm and check. Fever unknown, checked on 09/05/15 pm, ranging from 99.3 F to 102.5F. Ongoing, last checked 09/07/15 @ 7:30 Pm. Chills, shivering. Headache 09/05/15 mild, moderate, PM 09/05/15. ONGOING. NAUSEA 09/06/15 am. Increased HR 106-122, 09/06/15 AM. Ongoing. Decreased appetite 09/05/15 pm. Ongoing, on and off. Sore throat, noticed on 09/07/15, but doesn't hurt to swallow, no difficulty breathing. Slightly swollen. Swollen lymph nodes (2 on left side of neck) one midway down neckband smaller one in hairline, tender, swollen, moveable 09/07/15 (noticed) pm.
Second dose of vaccine administered after excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Second dose of vaccine administered after excursion) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Second dose of vaccine administered after excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Second dose of vaccine administered after excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
had a like a swollen lump under her arm pit that hurts; had a like a swollen lump under her arm pit that hurts; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on an unspecified date, as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On unspecified date, the patient had a like a swollen lump under her arm pit that hurts and reported that injection site not swollen only armpit. The clinical outcome of both events was unknown.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
36 y/o female who received seasonal influenza vaccine on 20 Dec 2010 as a condition of employment. Employee received the injection in her left mid-upper arm and did not note anything unusual about vaccine administration. She reports minimal redness, swelling, and tenderness at the vaccination site lasting <72 hours. Approximately 30 days following vaccine receipt, employee noted significant persistent left upper arm pain and intermittent swelling, primarily affecting the area of her vaccination site. Around the same time, she noted numbness in her left fingertips, which was intermittent for about 1-2 months, but has since subsided. Employee describes upper arm pain as "in my bone". Pain is significantly increased when pressure is applied against the affected area. Due to this pain, she has limited carrying infants in her left arm and she no longer carries her purse on the left side. Initially, the pain awoke her from her sleep, but she has learned to avoid positions that place pressure on her left upper arm. She notes a slight increase in pain when L)UE is held straight out in front of her, otherwise, she denies significant limitations in range of motion. Employee reports L)UE weakness. She has sought evaluation through her Primary care provider and was diagnosed with tennis elbow. She was prescribed LODINE and PERCOCET for pain management with improvement of pain, but she tries to limit medication use. About 3 weeks ago, a L)UE ultrasound was completed and reported as normal. Patient reported feeling well day of and prior to vaccinations. She denies significant or prolonged fever/chills, headaches, fatigue or generalized body aches following vaccine receipt. She denies a history of past trauma or injury to her L)UE. She reports no prior vaccine reactions. She reports a negative PMH except for asthma for which she uses an Albuterol inhaler.
Developed right sided headache with pain on right eye movements on 10/17 evening.  Starting around 10/20, developed slow right vision loss. By 10/22, had more rapidly progressive vision loss (with resolution of  headache).   Emergency Department Visit 10/24 with 20/400 vision uncorrected in R eye.  Seen 10/25 by optometry who diagnosed optic neuritis and referred to neuro ophthalmology. Continued extremely poor vision in right eye week of 10/25, with gradual improvement over the next week.  By  neuro-ophthalmology appointment on 11/8, complete resolution of right eye vision. Resolved without treatment
my arm was very sore; dizzy; headache; body aches; the arm I got all 3 shots in (right), the muscle hurts when I lift weights; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose, Anatomical location: Right arm -the arms got all 3 shots in (right)), for COVID-19 Immunization, reaction(s): "Had very sore arm"; Bnt162b2 (Second dose, Anatomical location: Right arm -the arms got all 3 shots in (right)), for COVID-19 Immunization, reaction(s): "confusion", "Felt extreme dizziness", "Severe headache", "Body aches". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "my arm was very sore"; DIZZINESS (non-serious), outcome "recovered", described as "dizzy"; HEADACHE (non-serious), outcome "recovered", described as "headache"; PAIN (non-serious), outcome "recovered", described as "body aches"; MYALGIA (non-serious), outcome "unknown", described as "the arm I got all 3 shots in (right), the muscle hurts when I lift weights". Therapeutic measures were taken as a result of pain in extremity, dizziness, headache, pain.  Additional information: She reported 16 hours after 1st dose, she had very severe sore arm. About 18 hours after 2nd dose, felt extreme dizziness, severe headache, confusion and body aches. She started feeling better about 12 hours later and all those symptoms completely went away by the time she woke up the next morning. About 18 hours after getting the booster, her arm was very sore and started feeling the same way she did after the 2nd shot. She was dizzy, headache, body aches, She took 600mg ibuprofen and within 4 hours she felt completely normal. About 2 months after getting the booster, the arms got all 3 shots in (right) the muscle thirst when she felt weights. It was never hurt before getting these shots.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Fever, chills, aching, sore arm, frequent urinating, watery/burning eyes, sore joints.
* 4/9/2021: Father in law went to get blood drawn for his INR (before 10am) * 4/9/2021: He started seeing some spots develop on his back. he did not tell anyone * 4/12/2021: Spots spread on his back. He told my mother in law. My sister in law took him to an urgent care. They ran blood and said results would take 3-4 days *4/16/2021: Urgent care said results could take two weeks. My sister in law took him to the medical center. They diagnosed shingles but also said his heart rate was low. My father in law was talking in circles/not making sense/acting confused so they ran the EKG to check pacemaker * 4/16/2021: Heart rate stabilised and they discharged with topical treatment for his shingles
Pt was due for his second dose of Moderna COVID vaccine primary series which should have been a 0.5 mL dose.  However the medical assistant who administered this dose unintentionally administered 0.25 mL instead (lower than authorized dose). This incident occurred on 12/15/21.  The medical assistant involved notified me of this incident today, 12/16/21.  No adverse effect has occurred.
L shoulder has continued to hurt from the shot.  Had shooting pain and soreness down to her wrist initially.  But went away after about a week.  Now with lifting the shoulder it is sore.  And when tries to sleep at night it hurts on  that side.   Is able to do yoga - but with certain stretches it hurts, reported 1 month after flu vaccine given. Pain with full ROM, but able to do it.  (11/24/2020).
I started having a extreme sore throat it felt like strep. I tested negative for a couple days. Three days after testing I was COVID-19 Positive.  I used Advil, Tylenol, and DAY and Night quill. I started to feel better in about three weeks after on 06/30/2022.  I still have residual fatigue and throat pain. I still can not taste or smell fully either.
Runny nose at least one episode of chest pain and palpatations lastong one hour nausea